ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,042.66
0.73%
US Tech 100
20,585.56
0.96%
다우존스 지수
44,734.06
-0.39%
Bitcoin
96,664.16
-0.61%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Moderna Inc (MRNA) 시세

Moderna Inc

Moderna Inc (MRNA)

NASDAQ
42.73
-0.33
( -0.77% )
업데이트: 00:15:45
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
42.73
매수가
42.71
매도가
42.73
거래량
1,078,050
42.07 일간 변동폭 43.80
35.80 52주 범위 170.47
market_cap
16.443B
전일 종가
43.06
개장가
43.41
최근 거래 시간
1
@
42.72
마지막 거래 시간
00:15:53
재정 규모
US$ 45,970,696
VWAP
42.6425
평균 볼륨(3m)
7,345,594
발행 주식
384,817,811
배당수익률
-
주가수익률
-3.47
주당순이익(EPS)
-12.25
매출
6.85B
순이익
-4.71B

Moderna Inc 정보

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.modernatx.com
본부
Wilmington, Delaware, USA
설립됨
-
Moderna Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker MRNA. The last closing price for Moderna was US$43.06. Over the last year, Moderna shares have traded in a share price range of US$ 35.80 to US$ 170.47.

Moderna currently has 384,817,811 shares in issue. The market capitalisation of Moderna is US$16.57 billion. Moderna has a price to earnings ratio (PE ratio) of -3.47.

Moderna (MRNA) 옵션 플로우 요약

전체 옵션 플로우 보기

전체 흐름

약세

순 프리미엄

-147M

Calls / Puts

21.95%

매수 / 매도

95.83%

OTM / ITM

13.64%

Sweeps 비율

0.00%

MRNA 최신 뉴스

추가 뉴스

Form 144 - Report of proposed sale of securities

30 11월 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

30 11월 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

30 11월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 11월 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

12 11월 2024
Edgar (US Regulatory)

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma PR Newswire PHILADELPHIA, Nov. 8, 2024 New findings showcase the potential of in vivo...

08 11월 2024
PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

08 11월 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 11월 2024
Edgar (US Regulatory)

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 PR Newswire PHILADELPHIA, Nov. 5, 2024 Pre-clinical data demonstrate robust...

05 11월 2024
PR Newswire (US)

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program, as the third Phase 3 trial for the investigational individualized neoantigen therapy, V940...

28 10월 2024
Business Wire
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.26-0.60479181204942.9946.341.47785585243.17655249CS
4-11.87-21.739926739954.656.69535.81102737842.74972141CS
12-30.75-41.848121937973.4879.958735.8734559452.78466227CS
26-97.02-69.4239713775139.75158.8235.8547949172.80069266CS
52-36.83-46.292106586279.56170.4735.8500949888.12273683CS
156-258.9-85.8336372377301.63321.30535.85162407135.2294627CS
26022.43110.49261083720.3497.1717.689231135146.0138665CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
SNTISenti Biosciences Inc
US$ 16.015
(641.44%)
68.58M
PPBTPurple Biotech Ltd
US$ 6.27
(86.89%)
20.03M
PRZOParaZero Technologies Ltd
US$ 1.825
(47.18%)
60.48M
JCSEJE Cleantech Holdings Limited
US$ 1.716
(44.20%)
10.25M
FOSLFossil Group Inc
US$ 2.04
(39.73%)
5.2M
MONDMondee Holdings Inc
US$ 0.46
(-35.23%)
653.89k
SDOTSadot Group Inc
US$ 3.91
(-25.52%)
262.9k
SMTKSmartKem Inc
US$ 5.00
(-20.26%)
57.2k
INVZWInnoviz Technologies Ltd
US$ 0.0759
(-20.11%)
1.98k
IFBDInfobird Company Ltd
US$ 2.65
(-19.70%)
212.52k
XTIAXTI Aerospace Inc
US$ 0.0469
(4.45%)
107.57M
SNTISenti Biosciences Inc
US$ 15.86
(634.26%)
68.68M
RGTIRigetti Computing Inc
US$ 3.2206
(5.59%)
68.32M
SGBXSafe and Green Holdings Corporation
US$ 0.6821
(39.20%)
67.02M
PRZOParaZero Technologies Ltd
US$ 1.82
(46.77%)
60.49M

MRNA Discussion

게시물 보기
axelvento axelvento 12 시간 전
Dr. Dave Weldon, Trump’s C.D.C. Pick, Was Not on Anyone’s Radar

Both his adult children are fully immunized, he said, and he prescribes thousands of doses of flu and other vaccines to his adult patients. “I’ve been described as anti-vaccine,” Dr. Weldon said, but “I give shots, I believe in vaccination.”

https://www.nytimes.com/2024/11/29/health/dave-weldon-cdc.html
👋 1 👍️ 1
axelvento axelvento 6 일 전
NEXT> Why a teenager’s bird-flu infection is ringing alarm bells for scientists

https://www.nature.com/articles/d41586-024-03805-4
👀 1 👍️ 1
axelvento axelvento 1 주 전
Johns Hopkins surgeon Makary is Trump’s pick to lead FDA "pro-vaccine"

https://www.healthcaredive.com/news/trump-fda-martin-makary-surgeon-nominate/733829/
👌 2 👍️ 1
reyprimero reyprimero 1 주 전
Mrna undervalued a lot, time to load the truck, IMO
👍️ 2 💯 3
Vexari Vexari 2 주 전
Manipulation is key

To the equation
👎️ 1 🗑️ 1 🚽 1 🤪 1 ⤵️ 1
axelvento axelvento 2 주 전
Our question is, what data is Mr. Kennedy talking about? Comprehensive national vaccine safety data are readily available to anyone. This includes the safety data used to license vaccines and data gathered after they have gone into use

https://www.nytimes.com/2024/11/20/opinion/rfk-jr-vaccines-public-health.html

$MRNA
👍️ 2 😄 1
axelvento axelvento 2 주 전
HSBC upgrades to Buy on underestimated pipeline potential
👍️ 2 🤙 1
axelvento axelvento 2 주 전
Trump gives RFK Jr McDonald’s ‘poison’ to eat on private plane

https://www.yahoo.com/news/trump-gives-rfk-jr-mcdonald-133657991.html
👍️ 1 😴 1 🤣 1
axelvento axelvento 2 주 전
Bears need to take into consideration the CMV data coming our this quarter. It's a 3-5 TAM drug with no competitors
I'd be careful shorting this right now!
👍️ 1
Stock Guy777 Stock Guy777 2 주 전
Amen to that!
👍️0
axelvento axelvento 2 주 전
Kennedy’s spokesperson did not respond to my request for comment last night as to whether, as HHS secretary, RFK Jr. would move to outlaw any existing vaccines, and referred me to his victory-lap post on X, which did not mention the topic

https://www.theatlantic.com/politics/archive/2024/11/trump-health-human-services-nomination/680674/

clown-
👍️0
axelvento axelvento 2 주 전
I agree$$$$$$$$
👍️0
DewDiligence DewDiligence 2 주 전
He won't be confirmed by the Senate, in my opinion.
👍️ 2 🙏 1 🤞 1
Stock Guy777 Stock Guy777 2 주 전
By the looks of the chart it has been finished! This thing was well into the 300s when I traded it from $80’s to 300+ and now look at it!! Look Out below! Just decided to come back and take a look. It’s obviously done horrible as did the” Shot”
👍️ 1
Bountiful_Harvest Bountiful_Harvest 2 주 전
Vaccine Stocks Slide Further After Trump Taps RFK Jr. To Lead HHS; CNN Outraged

https://www.zerohedge.com/markets/vaccine-stocks-slide-further-after-trump-taps-rfk-jr-lead-hhs

Moderna is finished...
👍️ 1
Stock Guy777 Stock Guy777 2 주 전
Yeah, good for you. I played this back in the day. And got out. I was never a fan, just knew before the actual vaccine was created, that it would run up.
👍️0
Stock Guy777 Stock Guy777 2 주 전
Yeah, for the better! Finally stopping these Frankenstein doctors and their controversial “shots” that play havoc on your whole body that I believe potentially killed my father early
👍️ 1
spartex spartex 2 주 전
Well right now it is having a huge impact on MRNA longs that are deeply under water if they haven't hedged with puts.

A four year low going all the way back to April 2020 period. Brutal. Glad I alerted the troops on this news yesterday to save themselves 7% or more downward draft today!
👍️0
axelvento axelvento 2 주 전
Trump’s latest controversial Cabinet pick could have a huge impact on Americans’ health and lives
https://edition.cnn.com/2024/11/15/politics/trump-rfk-cabinet-pick-american-health-analysis/index.html

the game$$$$$$$
👍️ 1 🤟 1
axelvento axelvento 2 주 전
RFK Jr. has built a reputation as a vaccine skeptic but has stopped short of adopting the “anti-vaxx” label attributed to him by critics. The former environmental lawyer has said his children are vaccinated and that he does not oppose safe vaccines.

relax$
👍️ 1 😃 1
axelvento axelvento 3 주 전
Kennedy has been one of the country’s most prominent anti-vaccine conspiracy theorists for years and has frequently spread falsehoods about the safety and efficacy of vaccines. Last week, Kennedy said he would “immediately” begin studying vaccine safety and efficacy but promised to not “take vaccines away from anybody.”
👍️0
Bountiful_Harvest Bountiful_Harvest 3 주 전
Shares of $MRNA and other hot shot stocks in full collapse on news of RFK joining the Trump admin

👍️0
spartex spartex 3 주 전
Big selling all of a sudden. Sub $40 now. 52 week low.

Appears that Trump will nominate Rfk Jr. to Health and Human Services Admin.

https://www.politico.com/news/2024/11/14/robert-f-kennedy-jr-trump-hhs-secretary-pick-00188617
😜 1
axelvento axelvento 3 주 전
next-
https://www.theguardian.com/society/2024/oct/23/doctors-trial-worlds-first-vaccine-against-vomiting-bug-norovirus
👍️ 4 🔜 1
Vexari Vexari 3 주 전
The majority shareholder of Moderna is?

When you are suffering

They are profiting
👇️ 1 🗑️ 1 🚽 1 🤪 1 🧻 1
axelvento axelvento 3 주 전
https://www.biospace.com/job-trends/biospace-announces-2025-best-places-to-work-in-biopharma
👋 1 👍 1
axelvento axelvento 3 주 전
Jpmorgan Chase & Co ownership in MRNA / Moderna, Inc.
On November 8, 2024 - Jpmorgan Chase & Co filed a 13F-HR form disclosing ownership of 2,227,044 shares of Moderna, Inc. (US:MRNA) valued at $148,833,351 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 12, 2024 disclosing 1,756,708 shares of Moderna, Inc.. This represents a change in shares of 26.77% during the quarter. The current value of the position is $104,292,471 USD.

https://fintel.io/so/us/mrna/jpmorgan-chase-
👍 2
axelvento axelvento 3 주 전
https://www.acsh.org/news/2024/11/07/dont-be-afraid-mrna-vaccines-49111
👍️ 3 🤙 1
axelvento axelvento 3 주 전
Moderna Buys Norwood Campus for $400M

https://bankerandtradesman.com/moderna-buys-norwood-campus-for-400m/#:~:text=Lab%20developer%20Alexandria%20Real%20Estate,core%20properties%20in%20Greater%20Boston.
👍️ 3 😀 1
axelvento axelvento 3 주 전
Moderna (MRNA) Q3 2024 Earnings Call Transcript

https://www.fool.com/earnings/call-transcripts/2024/11/07/moderna-mrna-q3-2024-earnings-call-transcript/
👍️ 4 ✌️ 1
EarningsCentral EarningsCentral 4 주 전
👍️0
axelvento axelvento 4 주 전
MRNA is set to report third-quarter 2024 earnings on Nov. 7, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $1.25 billion and a loss of $1.91 per share, respectively
👍️0
axelvento axelvento 1 월 전
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

https://investors.modernatx.com/news/news-details/2024/Merck-and-Moderna-Initiate-Phase-3-Trial-Evaluating-Adjuvant-V940-mRNA-4157-in-Combination-with-KEYTRUDA-pembrolizumab-After-Neoadjuvant-KEYTRUDA-and-Chemotherapy-in-Patients-With-Certain-Types-of-Non-Small-Cell-Lung-Cancer-NSCLC/default.aspx


huge news$
👍️ 1 🤑 1
axelvento axelvento 1 월 전
https://www.investing.com/news/company-news/piper-sandler-maintains-overweight-rating-on-moderna-stock-93CH-3680972
👋 1 👍️ 2
axelvento axelvento 1 월 전
20B market cap, 10B in cash, high potential pipeline in 4 therapeutic areas!
👍️ 2 💪 1
axelvento axelvento 1 월 전
Moderna has a whopping 33 million short share interest, but daily volume now a paper-thin 3.7 million

"Highest shorted stock on S&P500"
👍️ 1 🤣 1 ☝️ 1
axelvento axelvento 1 월 전
MRNA December 6th Options Begin Trading

https://www.nasdaq.com/articles/mrna-december-6th-options-begin-trading
👍️0
axelvento axelvento 1 월 전
Moderna’s norovirus vaccine enters Phase III trials in the UK
The firm hopes to file marketing applications in 2026 to have the vaccine approved by health regulators.

https://www.clinicaltrialsarena.com/news/modernas-norovirus-vaccine-enters-phase-iii-trials-in-the-uk/
👍️ 2 🤙 1
Vexari Vexari 1 월 전
Depends

On the road

That they're on
👎️ 1 🗑️ 1 🚽 1 🧻 1 0️⃣ 1
Vexari Vexari 1 월 전
All that is marketed

Is fear based
🌬️ 1 🎃 1 👎️ 1 🕳️ 1 🗑️ 1
gapole gapole 1 월 전
looks like meltdown here. where is the bad news? $53.54
👍️0
Monksdream Monksdream 1 월 전
MRNA new 52. Week low
👍️0
axelvento axelvento 1 월 전
Moderna stock touches 52-week low. bouncer
👍️0
axelvento axelvento 2 월 전
https://www.kcl.ac.uk/news/mrna-cancer-vaccine-potential-advanced-stage-cancer-patients-in-phase-1-trial
👍️ 1 ✌️ 1
jondoeuk jondoeuk 2 월 전
I couldn't find a PR or the poster.
👍️0
Vexari Vexari 2 월 전
Unraveling all the Lies of the Covid-19

Psychological Operation
👎️ 2 🗑️ 1 😎 1 🤥 1 🧻 1 0️⃣ 1
axelvento axelvento 2 월 전
$MRNA We are tackling cancer on an individual basis where we can take samples from each patient, understand their cancer, and design a therapy specifically for them

https://www.fastcompany.com/91202048/the-mrna-advantage
👍️ 1 🫨 1 ☝️ 1
tmonkey tmonkey 2 월 전
this one near a bottom-im in------tmonkey
👍️0
axelvento axelvento 2 월 전
https://www.globenewswire.com/news-release/2024/10/04/2958235/0/en/Global-mRNA-Cancer-Vaccine-Clinical-Trial-FDA-Approval-Market-Size-Future-Opportunity-Companies-Insight.html

$MRNA
👍️ 1 🤑 1
axelvento axelvento 2 월 전
Join us on Nov 8, as we, alongside
moderna_
, share promising data on anti-GPC3 in vivo CAR-M therapy for HCC. We'll also present TIP poster for the Ph1 study of anti-HER2 CAR-Monocytes targeting solid tumors.

https://ir.carismatx.com/news-releases/news-release-details/carisma-therapeutics-announces-upcoming-presentations-sitc-2024
👍️ 1 😃 1

최근 히스토리

NASDAQ
MRNA
Moderna
USOTC
OPNDF
Open Door (CE)
TG
8TC
BlackRock TCP Capital
TG
LO9A
VBI Vaccines
ASX
MKR
Manuka Resources
ASX
RXLDB
Rox Resources
TG
39CN
Carver Bancorp
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유